
Torsirin 40mg Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Irinotecan (40mg/2ml)
Overview Torsirin 40mg Injection
Oncozin 40mg Injection treats colorectal cancer by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, debility, and alopecia. This medication can suppress blood cell production, increasing infection risk. Report fever, sore throat, or persistent diarrhea immediately. Regular blood tests monitoring blood cell counts, cardiac function, liver health, and uric acid levels are necessary. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial medications. Drug interactions are possible; inform your healthcare provider of all medications you are taking. This injection is contraindicated during pregnancy and lactation; effective contraception is mandatory for both partners throughout treatment.
Uses of Torsirin 40mg Injection
Colorectal cancer
Major Benefits of Torsirin 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Torsirin 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Torsirin 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Torsirin 40mg Injection works:
The injectable drug Torsirin 40mg is a cancer treatment that inhibits topoisomerase I, an enzyme crucial for cancer cell DNA replication. This action reduces cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Torsirin 40mg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Torsirin 40mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional circumstances involving imminent maternal danger, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and the administration of Torsirin 40mg Injection are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Torsirin 40mg Injection can reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Employing Torsirin 40mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification might be unnecessary; however, medical advice is crucial. Dialysis patients should avoid this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Torsirin 40mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Torsirin 40mg Injection :
Omit a Torsirin 40mg Injection dose? Seek your physician's advice.
Facts to Know About Torsirin 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Camptothecin Analog |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | Topoisomerase inhibitor |
